Efficacy of GLP-1 Agonists for Weight Loss in Adults Without Diabetes - Clinical Advisor

Author reviews the pathophysiology of obesity including the role of incretin hormones and the mechanism of action, efficacy, and safety of GLP-1 receptor agonists as antiobesity medications.

Obesity was first recognized by the American Medical Association as a chronic disease requiring medical interventions in 2013.1 Although medications promoting weight loss have been available since th… [+13824 chars]

full article...